相似文献
1
Characterization of a cryptic rearrangement in a case of mantle cell lymphoma with negative FISH studies.
Blood Adv. 2019 Apr 23;3(8):1298-1302. doi: 10.1182/bloodadvances.2019031450.
2
An Uncommon Case of Double-Hit Mantle Cell Lymphoma That Demonstrates a Transformation Process.
Am J Clin Pathol. 2020 Jan 1;153(1):49-57. doi: 10.1093/ajcp/aqz133.
3
CD5-negative blastoid variant mantle cell lymphoma with complex CCND1/IGH and MYC aberrations.
Ann Lab Med. 2012 Jan;32(1):95-8. doi: 10.3343/alm.2012.32.1.95. Epub 2011 Dec 20.
4
Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.
Am J Clin Pathol. 2015 Feb;143(2):288-99. doi: 10.1309/AJCPUIDW2CPTA1JA.
5
Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7494-8. eCollection 2015.
6
Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region.
Cancer Genet Cytogenet. 2004 Oct 1;154(1):67-71. doi: 10.1016/j.cancergencyto.2004.02.002.
7
Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma.
Genes Chromosomes Cancer. 2021 Oct;60(10):678-686. doi: 10.1002/gcc.22977. Epub 2021 Jun 22.
8
Mantle cell lymphoma with aberrant expression of CD10.
Histopathology. 2008 Jul;53(1):20-9. doi: 10.1111/j.1365-2559.2008.03060.x. Epub 2008 Jun 2.
9
CCND1-IGH Fusion-Amplification and MYC Copy Number Gain in a Case of Pleomorphic Variant Mantle Cell Lymphoma.
Am J Clin Pathol. 2016 Dec;146(6):747-752. doi: 10.1093/ajcp/aqw194. Epub 2016 Dec 27.
10
Rapid detection of the t(11;14) translocation in mantle cell lymphoma by interphase fluorescence in situ hybridization on archival cytopathologic material.
Cancer. 2004 Apr 25;102(2):124-31. doi: 10.1002/cncr.11934.
引用本文的文献
1
Case report: Identification of atypical mantle cell lymphoma with rearrangement by next-generation sequencing.
Front Oncol. 2023 Mar 29;13:1145376. doi: 10.3389/fonc.2023.1145376. eCollection 2023.
2
Mate Pair Sequencing: Next-Generation Sequencing for Structural Variant Detection.
Methods Mol Biol. 2023;2621:127-149. doi: 10.1007/978-1-0716-2950-5_9.
3
Genomic profiling for clinical decision making in lymphoid neoplasms.
Blood. 2022 Nov 24;140(21):2193-2227. doi: 10.1182/blood.2022015854.
4
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
5
Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell Lymphomas.
Front Oncol. 2021 Nov 23;11:739441. doi: 10.3389/fonc.2021.739441. eCollection 2021.
6
Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma.
Genes Chromosomes Cancer. 2021 Oct;60(10):678-686. doi: 10.1002/gcc.22977. Epub 2021 Jun 22.
7
The pathologic diagnosis of mantle cell lymphoma.
Histol Histopathol. 2021 Oct;36(10):1037-1051. doi: 10.14670/HH-18-351. Epub 2021 Jun 11.
8
Molecular Pathogenesis of Mantle Cell Lymphoma.
Hematol Oncol Clin North Am. 2020 Oct;34(5):795-807. doi: 10.1016/j.hoc.2020.05.002. Epub 2020 Jul 22.
9
Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.
Blood Cancer J. 2019 Dec 16;9(12):103. doi: 10.1038/s41408-019-0255-z.
10
Cryptic insertions of the immunoglobulin light chain enhancer region near in t(11;14)-negative mantle cell lymphoma.
Haematologica. 2020 Aug;105(8):e408-e411. doi: 10.3324/haematol.2019.237073. Epub 2019 Nov 21.
本文引用的文献
1
and hijack immunoglobulin light-chain enhancers in cyclin D1 mantle cell lymphoma.
Blood. 2019 Feb 28;133(9):940-951. doi: 10.1182/blood-2018-07-862151. Epub 2018 Dec 11.
2
SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq).
Cancer Genet. 2018 Feb;221:1-18. doi: 10.1016/j.cancergen.2017.11.009. Epub 2017 Dec 2.
3
Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation.
Hum Pathol. 2017 Jun;64:207-212. doi: 10.1016/j.humpath.2017.01.001. Epub 2017 Jan 27.
4
The molecular pathogenesis of mantle cell lymphoma.
Leuk Lymphoma. 2017 Jul;58(7):1530-1537. doi: 10.1080/10428194.2016.1248965. Epub 2016 Nov 28.
5
CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma.
Oncotarget. 2016 Nov 8;7(45):73558-73572. doi: 10.18632/oncotarget.12434.
6
BIMA V3: an aligner customized for mate pair library sequencing.
Bioinformatics. 2014 Jun 1;30(11):1627-9. doi: 10.1093/bioinformatics/btu078. Epub 2014 Feb 12.
7
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18250-5. doi: 10.1073/pnas.1314608110. Epub 2013 Oct 21.
8
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.
Blood. 2013 Feb 21;121(8):1394-402. doi: 10.1182/blood-2012-08-452284. Epub 2012 Dec 18.
9
Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features.
Cancer Res. 2012 Oct 15;72(20):5307-16. doi: 10.1158/0008-5472.CAN-12-1615. Epub 2012 Aug 20.
10
An assessment of the usefulness of immunohistochemical stains in the diagnosis of hairy cell leukemia.
Am J Clin Pathol. 2011 Sep;136(3):390-9. doi: 10.1309/AJCP5GE1PSBMBZTW.
Zotero 插件